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584 Abstracts February 2015medical comorbidities, including ventilator dependence (2.1% vs 0.1%; P <
.01), congestive heart failure (8.7% vs 3.1%; P < .01), recent myocardial
infarction (4.5% vs 2%; P < .01), and insulin dependence (59.6% vs 53.6%;
P ¼ .03) compared with the NRA group. Preoperative vascular disease was
more severe in the RA group as well, with rest pain/gangrene (50.9% vs
39.1%; P < .01) and history of amputation (73.1% vs 49.8%; P < .01)
both higher in the RA group. The RA group also had a higher proportion
of emergency procedures (11.4% vs 4.4%; P < .01), longer operative time
(2266 11.5 minutes vs 208.46 2.6 minutes; P < .01) and longer prior hos-
pital length of stay (16.56 1.8 days vs 86 0.3 days; P < .01). The RA group
also was taken back to the operating room more frequently during the index
admission (36.2% vs 15.3%; P < .01) than the NRA group. Preoperative hy-
pertension (odds ratio, 46.7; 95% conﬁdence interval, 34.6-62.9) and rest
pain/gangrene (odds ratio, 50.1; 95% conﬁdence interval, 36.4-69.1) were
the only independent predictors of RA on multivariate analysis.
Conclusions: Insulin dependence and preoperative cardiac comorbid-
ities are not predictive of readmission rates after FPB in diabetic patients.
The presence of critical limb ischemia is the most predictive factor for 30-
day readmission after FPB in diabetic patients.
Author Disclosures: K. H. Nagarsheth: None; J. Schor: None; K.
Singh: None; M. D’Alessandro: None; S. Zia: None; J. Deitch: None.The da Vinci Robot in the Field of Vascular SurgeryTable I. Demographic, characteristics, and outcomes of patients with











Age, years 73.8 6 8.4 77.9 6 8.4 73.6 6 8.5 <.001
Female gender 20.4 33.8 20.0 .004Petr Stadler, MD, PhD, Libor Dvoracek, MD, Petr Vitasek, MD,
Pavel Matous, MD. Na Homolce Hospital, Praha 5, Czech Republic
Objectives: The da Vinci system has been used by a variety of disciplines
for laparoscopic procedures, but the use of robots in vascular surgery is still rela-
tively unknown. The feasibility of laparoscopic aortic surgery with robotic assis-
tance has been sufﬁciently demonstrated. Our clinical experience with robot-
assisted vascular surgery performed using the da Vinci system is described.
Methods: Between November 2005 and May 2014, we performed
310 robot-assisted vascular procedures. A total of 224 patients were pro-
spectively evaluated for occlusive diseases, 61 patients for abdominal aortic
aneurysm (Fig), 4 for a common iliac artery aneurysm, 4 for a splenic artery
aneurysm, 1 for an internal mammary artery aneurysm, 5 for hybrid proce-
dures, 2 for median arcuate ligament release, and 9 for type II endoleak
treatment after endovascular aneurysm repair.
Results: A total of 299 cases (96.5%) were successfully completed
robotically, and one patient’s (0.3%) surgery was discontinued during lapa-
roscopy due to heavy aortic calciﬁcation. Conversion was necessary in 10 pa-
tients (3.2%). The 30-day mortality rate was 0.3%, and early nonlethal
postoperative complications were observed in six patients (1.9%).
Conclusions: Our experience with robot-assisted laparoscopic sur-
gery has demonstrated the feasibility of this technique for occlusive diseases,
aneurysms, type II endoleak treatment after endovascular aneurysm repair,
for median arcuate ligament release, and hybrid procedures.Fig. The central anastomosis of the robotic abdominal aortic aneurysm
repair.
Maximum diameter 57.7 6 22.6 61.4 6 11.9 57.6 6 22.9 .14
Graft body diameter 27.2 6 3.9 28.8 6 3.9 27.2 6 3.6 <.001
Unplanned graft
extension
10.4 32.1 9.6 <.001
Hospital death 0.7 5.0 0.6 .002
Dysrhythmia 3.4 8.8 3.2 .018
Reoperation 2.0 5.0 1.9 .08
1-year mortality 5.7 8.8 5.6 .22
aData are shown as mean 6 standard deviation or as percentage.Author Disclosures: P. Stadler: None; L. Dvoracek: None; P. Vitasek:
None; P. Matous: None.Type I Endoleak at Completion of Endovascular
Abdominal Aneurysm Repair Is Associated With
Increased Perioperative Mortality
Tze-Woei Tan, MD1, Mohammad Eslami, MD2, Wayne W. Zhang, MD1,
Denis Rybin2, Doros Gheorghe2, Alik Farber, MD2. 1Louisiana State
University Health Sciences Center Shreveport, Shreveport, La; 2Boston
University Medical Center, Boston, Mass
Objectives: Type I endoleak (TIE) during endovascular abdominal
aortic aneurysm repair (EVAR) is usually identiﬁed and treated intraopera-
tively. We evaluated the outcomes of patients who, despite possible treat-
ment, had TIE at completion of EVAR.
Methods: We examined consecutive EVAR within the Vascular Study
Group of New England database (2003-2012), and the outcomes of patients
who had TIE at completion were compared with those who did not.
Ruptured abdominal aortic aneurysms were excluded. Outcomes included
perioperative death, cardiac complication, reoperation, and 1-year mortality.
Multivariable logistic regression was used to determine factors associated
with perioperative mortality as well as factors associated with TIE.
Results: Among the 2402 EVARs in the study cohort, 2235 (93%)
were performed electively; 167 (7%) had a symptomatic abdominal aortic
aneurysm. A TIE was present in 80 patients (3.3%) at completion of surgery;
these patients were older, more likely to be female, have a larger endograft
main body diameter, and have unplanned graft extension (Table). TIE was
associated with increased postoperative mortality (5% vs 0.6%; P ¼ .002)
and cardiac dysrhythmia (8.8% vs 3.2%; P ¼ .02). Four patients underwent
intraoperative conversion to open repair and none died before hospital
discharge. In multivariable analysis, TIE was associated with increased peri-
operative mortality (odds ratio [OR], 4.6; 95% conﬁdence interval [CI],
1.3-16.7; P ¼ .02). Other factors associated with perioperative death
included female gender (OR, 4.6; 95% CI, 1.7-12.8; P ¼ .003) and cardiac
dysrhythmia (OR, 17.5; 95% CI, 6.0-50.6); p30mm (OR, 2.5; 95% CI, 1.6-
4.4; P < .001) and unplanned graft extension (OR, 4.2; 95% CI, 2.5-7.3;
P < .001).
Conclusions: TIE at EVAR completion occurs in up to 3% of patients
and is associated with increasing age, female gender, larger endograft diam-
eter, and unplanned graft extension. TIE is associated with increased risk of
perioperative mortality. Additional study is needed to further deﬁne and
improve perioperative outcomes of these at-risk patients.Author Disclosures: T. Tan: None; M. Eslami: None; W. W. Zhang:
None; D. Rybin: None; D. Gheorghe: None; A. Farber: None.Patients With Familial Abdominal Aortic Aneurysms Are at
Increased Risk for Type 1 Endoleak Following Elective
Endovascular Aneurysm Repair
Biju K. Thomas, MD, Evan J. Ryer, MD, Robert P. Garvin, MD, Helena
Kuivaniemi, MD, Ph.D., David P. Franklin, MD, James R. Elmore, MD.
Geisinger Medical Center, Danville, Pa
Objectives: A recent investigation has documented increased aneu-
rysm-related complications after endovascular abdominal aortic aneurysm
(AAA) repair (EVAR) of familial AAAs (fAAAs). We hypothesized that
fAAA patients are not at increased risk after EVAR compared with EVAR
for sporadic AAAs (spAAA). To this end, we performed a retrospective re-
view of our single institution series.
Methods: Epidemiologic data was collected through the electronic
medical record. Major adverse events were deﬁned as myocardial infarction,
cardiac arrest, respiratory failure requiring tracheostomy, renal failure
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requiring amputation, multisystem organ failure, or death. Endoleaks
were classiﬁed in accordance with the standardized reporting practices of
the Society for Vascular Surgery.
Results: A total of 391 patients with complete family history and clin-
ical data underwent elective AAA repair from 2004 to 2014. Demographics
were consistent with a standard AAA population and did not differ between
fAAA and spAAA patients. Sixty-two percent (n ¼ 56) of fAAA patients and
68% (n ¼ 203) of spAAA patients underwent EVAR (P ¼ .31). The fAAA
patients did not incur any greater risk of major adverse events after EVAR
(fAAA: 11% vs spAAA: 9%; P ¼ .8) or open AAA repair (fAAA: 11% vs
spAAA: 15%; P ¼ .78). Despite no difference in major morbidity, the
fAAA patients did have an increased rate of all types of endoleak (fAAA:
23% vs spAAA: 12%; P ¼ .05). Furthermore, the rate of type I endoleak
and subsequent reintervention for type I endoleak did differ between the
groups (fAAA: 7% vs spAAA: 1%; P ¼ .02). In contrast, reintervention for
all types of endoleak after EVAR (fAAA: 13% vs spAAA: 8%; P ¼ .16) did
not differ between fAAA and spAAA patients.
Conclusions: The current study demonstrates that patients with fAAA
do not have increased morbidity after AAA repair but are more prone to
endoleak after EVAR. We believe our results, combined with those of others,
suggest EVAR for fAAA is safe and effective but fAAA patients represent a
subpopulation that would beneﬁt from close postprocedural surveillance.
Author Disclosures: B. K. Thomas: None; E. J. Ryer: None; R. P.
Garvin: None; H. Kuivaniemi: None; D. P. Franklin: None; J. R.
Elmore: None.Fig. Elective abdominal aorta aneurysm repair mortality prediction model
(C ¼ 0.853).External Validation of Vascular Group of New England
Risk Predictive Model of Mortality After Elective
Abdominal Aorta Aneurysm Repair and Comparison
Against Established Models
Mohammad H. Eslami, MD1, Denis Rybin, MS2, Gheorghe Doros, PhD2,
Alik Farber, MD1. 1Division of Vascular and Endovascular Surgery, Boston
University School of Medicine, Boston, Mass; 2Department of Biostatistics,
Boston University School of Public Health, Boston, Mass
Objectives: We previously developed a Vascular Group of New En-
gland (VSGNE) risk-predictive model (RPM) to predict in-hospital mortality
(IHM) after elective abdominal aorta aneurysm repair (EAR). The purpose of
this study was to externally validate this model using American College of Sur-
geons’ National Surgical Quality Improvement Program (NSQIP) database
and evaluates its ability to predict mortality compared with established RPMs.
Methods: The VSGNE AAA database was queried for patients who
underwent EAR. Only preoperative variables, Anesthesia Society Associa-
tion (ASA) Physical Status Classiﬁcation, and type of procedure were
entered into a logistic regression model as predictors of IHM. Backward
elimination procedure with a level of 0.2 was used to select a more parsimo-
nious model. Calibration was performed to measure how closely predicted
outcomes agreed with observed outcomes. The predictive value of the
model was assessed via C statistic. The Hosmer-Lemeshow (HL) method
was used to assess calibration. The external validation of this model was per-
formed using the NSQIP EAR sample. This model was then compared with
Medicare and the Glasgow Aneurysm Score for predicting IHM in the
NSQIP sample. Vuong test was performed to compare model ﬁt. Model
discrimination was assessed in equally sized risk-group NSQIP terciles.
Results: Data from 2,681 patients from the VSGNE sample with
overall 1.3% IHM rate were used to develop a parsimonious AAA mortality
model (Table). The internally validated model showed a very high discrim-
inating ability (corrected C ¼ 0.805) and good model ﬁt (P ¼ .699 by HL).
External validation on 18,766 NSQIP patients with an overall 1.9% IHMTable. Abdominal aortic aneurysm (AAA) ﬁnal risk-predictive model
(RPM) of mortality
Variable B SE P value
Intercept e12.54 2.17 <.001
Open procedure 1.35 0.37 <.001
Age 0.09 0.03 .001
Female gender 0.88 0.36 .014
Myocardial disease 0.62 0.36 .088
Vascular disease 0.80 0.42 .060
Congestive heart failure 0.88 0.41 .032
COPD 0.55 0.36 .126
ASA: life threat/moribund 0.90 0.80 .260
ASA, American Society of Anesthesiologists; COPD, chronic obstructive
pulmonary disease; SE, standard error.rate showed very good predictive ability (area under the curve ¼ .737;
Fig). Vuong tests yielded a signiﬁcant ﬁt difference favoring Medicare and
VSGNE to Glasgow Aneurysm Score model, whereas Medicare and
VSGNE compared similarly (Fig). Across three risk terciles, the VSGNE
model predicted observed mortality reasonably well.
Conclusions: The VSGNE AAA RPM was externally validated on
NSQIP AAA patients and showed a high ﬁdelity for predicting EARmortality
performed by a diverse array of physicians. A risk score based on this model
can reliably stratify patients according to their risk of mortality after EAR.
Author Disclosures: M. H. Eslami: None; D. Rybin: None; G. Doros:
None; A. Farber: None.Celiac Artery Decompression for Median Arcuate Ligament
Syndrome: A United States National Inpatient Sample
Study
Alec B. Rezigh, BS1, Sapan S. Desai, MD2, Rana O. Aﬁﬁ, MD1, Kristofer
M. Charlton-Ouw, MD1, Charles C. Miller, PhD1, Anthony L.
Estrera, MD1, Hazim J. Saﬁ, MD1, Ali Azizzadeh, MD1. 1The University
of Texas at Houston Medical School, Houston, Tex; 2Southern Illinois
University School of Medicine, Springﬁeld, Ill
Objectives: Median arcuate ligament syndrome (MALS) results from
celiac artery compression by the MAL and is most often associated with
chronic abdominal pain. The objective of this study was to evaluate the out-
comes of MALS after celiac artery decompression (CAD).
Methods: A retrospective analysis was completed using theNationwide
Inpatient Sample based on International Classiﬁcation of Diseases, Ninth
Revision, Clinical Modiﬁcation codes for MALS (447.4) and CAD (39.91)
for patient admissions between 1999 and 2011 in the U.S. Demographic
covariates included age and gender. Clinical covariates included Diagnosis-
Related Group (DRG) severity of illness scores, mortality scores, comorbid-
ities, and hospital covariates. Outcomes included inpatient mortality, median
length of stay in days, and adjusted median hospital costs. Data analysis was
completed using the IBM SPSS 20 software (IBM Corp, Armonk, NY).
Results: We identiﬁed 33,951 patients who were diagnosed with
MALS and 1029 patients who underwent CAD. Demographics, comorbid-
ities, hospital covariates, and outcomes are reported in the Table. Although
the results indicate increased mortality in patients who do not undergo sur-
gery (MALS: 2.6% vs CAD: 0%; P < .001), this is more likely due to higher
DRG severity of illness (MALS: 2.7; CAD: 1.7; P < .001) and risk of mor-
tality (MALS: 2.3; CAD: 1.2; P < .001). The incidence of MALS has
increased steadily since the year 2000, yet only 2.44% of patients, on
average, identiﬁed with MALS undergo CAD.
Conclusions: The outcomes of CAD for MALS are excellent. While
the incidence of MALS has increased, very few patients undergo CAD.
This may represent an opportunity to educate physicians regarding the diag-
nosis and treatment of MALS.
